R. V. McCloskey

Susceptibility of the Bacteroides fragilis group in the United States in 1981

Francis P. Tally, G J Cuchural, N V Jacobus et al. · Antimicrobial Agents and Chemotherapy · 1983 · 109 citations · Full text

Susceptibility Testing, Resistance Rate, Antimicrobial Chemotherapy +19

Inhibition of Immunoreactive Tumor Necrosis Factor-  by a Chimeric Antibody in Patients Infected with Human Immunodeficiency Virus Type 1

Robert Walker, Katie Spooner, Gerald D. Kelly et al. · The Journal of Infectious Diseases · 1996 · 68 citations

Meningitis caused by Campylobacter fetus ssp jejuni.

Ragnar Norrby, R. V. McCloskey, Gunilla Zackrisson et al. · BMJ · 1980 · 37 citations · Full text

Serum Ampicillin Concentrations, Drug Resistance, Medical Microbiology +18

Comparative clinical trial of imipenem-cilastatin (N-formimidoyl-thienamcyin-dehydropeptidase inhibitor) and cefazolin

Robert L. Marier, R. V. McCloskey, G. D. Dickenson et al. · Journal of Antimicrobial Chemotherapy · 1983 · 31 citations

Effect of Hemodialysis and Renal Failure on Serum and Urine Concentrations of Cephapirin Sodium

R. V. McCloskey, Elizabeth Terry, A. W. McCracken et al. · Antimicrobial Agents and Chemotherapy · 1972 · 30 citations · Full text